Repetitive Transcranial Magnetic Stimulation Treats Tinnitus

This article originally appeared here.
Share this content:
Repetitive Transcranial Magnetic Stimulation Treats Tinnitus
Repetitive Transcranial Magnetic Stimulation Treats Tinnitus

FRIDAY, July 17, 2015 (HealthDay News) -- Repetitive transcranial magnetic stimulation (rTMS) can improve tinnitus severity, according to a study published online July 16 in JAMA Otolaryngology-Head & Neck Surgery.

Robert L. Folmer, Ph.D., from the Portland Veterans Affairs Medical Center in Oregon, and colleagues conducted a randomized, participant and clinician or observer-blinded trial to determine whether rTMS can reduce the perception or severity of tinnitus. Seventy individuals who experienced chronic tinnitus were randomized to receive active or placebo rTMS; 64 individuals were included in data analyses. On 10 consecutive workdays, participants received 2,000 pulses per session of active or placebo rTMS at a rate of 1-Hz rTMS daily. The main study outcome was the Tinnitus Functional Index, which was compared at baseline and post-treatment.

The researchers found that 56 percent of the active rTMS group and 22 percent of the placebo group were responders to rTMS treatment. There was a statistically significant difference in the percentage of responders to treatment in each group (P < 0.005).

"Improvements in tinnitus severity experienced by responders were sustained during the 26-week follow-up period," the authors write. "Before this procedure can be implemented clinically, larger studies should be conducted to refine treatment protocols."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

CDC Concerned About Falling Flu Vaccination Rates

CDC Concerned About Falling Flu Vaccination Rates

Decline among vulnerable older adults is of particular concern

One in Five With Non-Valvular A-Fib Receiving Digoxin

One in Five With Non-Valvular A-Fib Receiving Digoxin

Indication for digoxin use was considered inappropriate in 59.8 percent in Turkish cohort

Rapid, Successful Response to ART for Many Patients With HIV

Rapid, Successful Response to ART for Many Patients ...

Factors associated with virological success include having undetectable viral load, use of three drugs

is free, fast, and customized just for you!

Already a member?

Sign In Now »